Author

S. Jois

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Dahai· 1 shared F. Musarrat· 1 shared K. Kousoulas· 1 shared R. Nabi· 1 shared V. Chouljenko· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Dahai

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections

F. Musarrat, V. Chouljenko, R. Nabi, A. Dahai, S. Jois, K. Kousoulas

This paper shows that nelfinavir mesylate inhibits SARS-CoV-2 S glycoprotein-mediated cell fusion, suggesting its potential as an antiviral against COVID-19.

bioRxiv · Apr 24, 2020Microbiology